• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viral Immunol . Assessment of S-Specific IgG and IgM Positive Rates in Healthy Hospital Staff Members Vaccinated with the Inactivated SARS-CoV-2 Va

tetano

Editor, Senior Moderator
Viral Immunol


. 2022 Feb 15.
doi: 10.1089/vim.2021.0110. Online ahead of print.
Assessment of S-Specific IgG and IgM Positive Rates in Healthy Hospital Staff Members Vaccinated with the Inactivated SARS-CoV-2 Vaccine


Lijun Zhou[SUP] 1 2 [/SUP], Dabin Liu[SUP] 1 2 [/SUP], Huihua Zhang[SUP] 1 2 [/SUP], Limei Wu[SUP] 1 2 [/SUP], Xuehui Liu[SUP] 1 2 [/SUP], Xiaoyan Wang[SUP] 1 2 [/SUP], Shuyan Liu[SUP] 1 2 [/SUP], Shaomin Yan[SUP] 1 2 [/SUP], Zhihai Li[SUP] 1 2 [/SUP], Shaoguo Wu[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Widespread vaccination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine makes the assessment of antibodies' positive rates essential. In this study, a total of 378 hospital staff members vaccinated with the vaccine were selected as research subjects. Serum-specific IgG and IgM against the SARS-CoV-2 spike protein (S) were detected, and S-specific IgG and IgM positive rates were analyzed in different age and sex groups, as was the serological pattern of IgG/IgM. The positive rates of IgG and IgM were 92.06% and 44.44%, respectively. The percentage of both IgG and IgM positive (IgG[SUP]+[/SUP]IgM[SUP]+[/SUP]) was 43.92%. A total of 182 vaccinees (46.90%) were IgG positive and IgM negative (IgG[SUP]+[/SUP]IgM[SUP]-[/SUP]), and 28 vaccinees (7.41%) were negative for both IgG and IgM (IgG[SUP]-[/SUP]IgM[SUP]-[/SUP]); 2 participants were positive for IgM alone (IgG[SUP]-[/SUP]IgM[SUP]+[/SUP]). In sex subgroups, the rate of IgM positivity was significantly higher in the male group than in the female group (p = 0.027). In different age subgroups, positive rates for IgG in the young group were significantly higher than those in the other group (p = 0.035). Furthermore, ratios of sample values to cutoff values (S/CO values) for IgG in vaccinees who were S-specific IgG positive were compared, and the S/CO values of IgG were significantly higher in the younger group than in the other group (p < 0.001). When comparing the influence of sex on two specific serological patterns (IgG[SUP]+[/SUP]IgM[SUP]-[/SUP] and IgG[SUP]+[/SUP]IgM[SUP]+[/SUP]), a significant difference in positivity rates was detected (p = 0.011). Male vaccinees were more likely than females to have an IgG[SUP]+[/SUP]IgM[SUP]+[/SUP] pattern.

Keywords: COVID-19; IgG; IgM; SARS-CoV-2; inactivated vaccine.
 
Back
Top Bottom